Skip to Content

Trastuzumab

In the US, Trastuzumab (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC03

CAS registry number (Chemical Abstracts Service)

0180288-69-1

Chemical Formula

C6470-H10012-N1726-O2013-S42

Therapeutic Categories

Antineoplastic agent

Biological response modifier, BRM

Immunomodulator

Anti-HER2 monoclonal antibody

Chemical Name

Immunoglobulin G1 (human-mouse monoclonal rhuMab HER2γ₁-chain antihuman p185c-erbB²receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer (WHO )

Foreign Names

  • Trastuzumabum (Latin)
  • Trastuzumab (German)
  • Trastuzumab (French)
  • Trastuzumab (Spanish)

Generic Names

Brand Names

  • Herceptin
    Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche LTD, Serbia; Genentech, Georgia; Genentech, United States; Genentech Inc., Oman; Hoffmann La Roche, Kuwait; Hoffmann-La Roche, Canada; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche Pharmaceutical, China; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Registration, Slovenia; Roche Uruguay, Uruguay
  • Herceptin 150mg
    Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Herceptin 440mg
    Roche Pharma Schweiz, Switzerland
  • Herceptin 600mg
    Abacus, Austria; Haemato Pharm, Austria; Orifarm, Austria; Roche, Hungary; Roche Registration, Austria
  • Herceptin 600mg/5ml
    Roche, Luxembourg; Roche Pharma Schweiz, Switzerland
  • Herceptin SC
    Productos Roche, Chile; Roche, New Zealand; Roche Products, Australia
  • Herceptin SC 600mg/5ml
    Roche, Israel
  • Hertraz
    Biocon, Georgia
  • Herzuma
    Celltrion, Slovenia
  • Kadcyla
    Productos Roche, Chile; Roche, Bosnia & Herzegowina; Roche, Cyprus; Roche, Croatia (Hrvatska); Roche, Poland; Roche, Turkey; Roche Farma, Peru; Roche Registration Limited, Iceland
  • Kadcyla 160mg
    Roche, Hungary
  • Kanjinti
    Amgen Europe, Netherlands; Amgen Europe, Slovenia
  • Ontruzant
    Samsung Bioepis, Latvia; Samsung Bioepis UK, Netherlands
  • Perjeta-Herceptin [+ Pertuzumab]
    Hoffmann-La Roche, Canada
  • Trastuzumab Baxter
    Baxter, New Zealand
  • Zedora
    Libbs, Brazil
  • Kadcyla
    Chugai Pharmaceutical, Japan; DSM Pharmaceuticals, Georgia; F. Hoffmann-La Roche LTD, Serbia; Genentech, United States; Hoffmann-La Roche, Canada; Roche, Argentina; Roche, Belgium; Roche, Brazil; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Estonia; Roche, Spain; Roche, Finland; Roche, France; Roche, Hong Kong; Roche, Ireland; Roche, Israel; Roche, Lithuania; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Sweden; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Ltd, Greece; Roche Registration, Slovenia
  • Kadcyla 100mg
    Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Kadcyla 160mg
    Orifarm, Austria; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Trazimera
    Pfizer, Netherlands

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide